Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass balance, pharmacokinetics, and metabolism study of oral [14C]-RO5285119 in healthy men
NL-OMON41196Active, not recruiting
- Sponsor
- Roche
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of balovaptan in Autism Spectrum Disorder (ASD), sponsored by Roche. Primary endpoints: Routes and rates of elimination of [14C]-labeled RO5285119 and Pharmacokinetics of total drug-related material, RO5285119, and metabolites. Started Jun 2014; status: active, not recruiting.
02
Drugs
balovaptan
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NL-OMON41196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41196.